LineaBio Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Joint Venture

  • Financing Rounds
  • 1

LineaBio General Information

Description

Manufacturer of drug products intended to serve the cell and gene therapy industry. The company specializes in both unmodified iPSC lines and iPSC lines modified with gene editing tools to enhance the utility of therapeutic cells, thereby enabling therapeutic developers to cut costs and accelerate timelines to GMP.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • MaRS Centre, West Tower
  • 661 University Avenue, Suite 1002
  • Toronto, Ontario M5G 1M1
  • Canada
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • MaRS Centre, West Tower
  • 661 University Avenue, Suite 1002
  • Toronto, Ontario M5G 1M1
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LineaBio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore LineaBio‘s full profile, request access.

Request a free trial

LineaBio Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore LineaBio‘s full profile, request access.

Request a free trial

LineaBio FAQs

  • When was LineaBio founded?

    LineaBio was founded in 2023.

  • Where is LineaBio headquartered?

    LineaBio is headquartered in Toronto, Canada.

  • What industry is LineaBio in?

    LineaBio’s primary industry is Drug Discovery.

  • Is LineaBio a private or public company?

    LineaBio is a Private company.

  • What is LineaBio’s current revenue?

    The current revenue for LineaBio is .

  • Who are LineaBio’s investors?

    Centre for Commercialization of Regenerative Medicine and OmniaBio have invested in LineaBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process